Tazarotene is a third-generation retinoid that is more potent and receptor-selective than Tretinoin. At 0.05%, it is the starting strength for treating stubborn acne vulgaris and plaque psoriasis. Tazarotene binds specifically to RAR-beta and RAR-gamma receptors, making it particularly effective for resistant skin conditions.
| Active Ingredient | Tazarotene 0.05% |
| Size | 15g tube |
| Form | Topical gel |
| Class | Third-generation retinoid (acetylenic) |
| Treats | Acne, psoriasis, photoaging |
| Tazarotene | Tretinoin | |
| Generation | 3rd | 1st |
| Potency | Higher | Standard |
| Best For | Stubborn acne, psoriasis | General acne, anti-aging |
| Irritation | Higher | Moderate |
Important: Do NOT use during pregnancy. Tazarotene is Category X — absolutely contraindicated in pregnancy.
Q: When should I choose Tazarotene over Tretinoin?
A: If your acne or psoriasis has not responded to Tretinoin 0.1%, Tazarotene may be more effective.
Q: Can I step up to 0.1%?
A: Yes, after 2-3 months if tolerated. See Tazarotene 0.1%.
Tazarotene is a potent topical retinoid. Use it only as directed by a qualified clinician and apply a thin layer rather than increasing the amount. Skin is commonly introduced to retinoids gradually, with a gentle cleanser and moisturizer used to support comfort. Avoid the eyes, lips, corners of the nose, broken skin, and areas affected by sunburn or irritation. Daily broad-spectrum sunscreen and sensible sun protection are essential.
Do not use tazarotene during pregnancy or when attempting to become pregnant; obtain individualized medical guidance before use. Tell your clinician about other retinoids, exfoliating acids, acne treatments, waxing, or procedures in your routine. Redness, peeling, dryness, and sensitivity can occur, particularly during the adjustment period. Stop and seek professional advice for severe or persistent reactions. This product should not be selected only by strength: vehicle, skin tolerance, treatment goal, and clinician instructions all matter.